Appropriation of the Connected Solution Freestyle Libre® in Adult Patients With Diabetes in the Context of Therapeutic Education

NCT ID: NCT04739124

Last Updated: 2023-09-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

86 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-06-10

Study Completion Date

2023-09-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Following the proposal to self-monitor by the Freestyle Libre® (FSL) connected object, in diabetic patients in the context of therapeutic education, regarding the appropriation of FSL, what works, for which patients , in what specific contexts and by what mechanisms does it govern? A multicentric observational research will be conducted with mixed method design (follow-up using patient questionnaires) and semi-structured interviews of patients and caregivers.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Diabetic patients

Patients presenting type 1 or type 2 diabetes, eligible for the prescription of Freestyle Libre

Follow-up questionnaires

Intervention Type OTHER

The patient normally follows the education program as usual but research specific data is collected:

* Biological sampling at the start and end of the education program (glycated hemoglobin).
* Retrieval of usage and glycemic balance data from the Libreview online platform (at one week, one month and three months of use)
* Iterative questionnaires allowing the study of factors of acceptance, appropriation and use (at the start of the study, at 4 weeks, at 12 weeks)

Interviews

Intervention Type OTHER

Semi-structured interviews will be carried out during the visits, either face-to-face or remotely.

Caregivers

Caregiver caring for diabetic patients and practicing therapeutic education on a regular basis

Follow-up questionnaires

Intervention Type OTHER

The patient normally follows the education program as usual but research specific data is collected:

* Biological sampling at the start and end of the education program (glycated hemoglobin).
* Retrieval of usage and glycemic balance data from the Libreview online platform (at one week, one month and three months of use)
* Iterative questionnaires allowing the study of factors of acceptance, appropriation and use (at the start of the study, at 4 weeks, at 12 weeks)

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Follow-up questionnaires

The patient normally follows the education program as usual but research specific data is collected:

* Biological sampling at the start and end of the education program (glycated hemoglobin).
* Retrieval of usage and glycemic balance data from the Libreview online platform (at one week, one month and three months of use)
* Iterative questionnaires allowing the study of factors of acceptance, appropriation and use (at the start of the study, at 4 weeks, at 12 weeks)

Intervention Type OTHER

Interviews

Semi-structured interviews will be carried out during the visits, either face-to-face or remotely.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients

* Have type 1 or type 2 diabetes (as included in the education program),
* Be of legal age (over 18 years old),
* Do not present legal protection measures due to incapacity (such as guardianship or guardianship).
* Be able to read and speak French (elementary school level)
* Be eligible for FSL prescription and authorize the sharing of your data in Libreview®
* Be affiliated to a social security scheme
* Have an email address or a phone allowing internet use
* Caregivers

* Be registered on the roll of his professional order
* Hold the certificate of 40 hours of training in therapeutic education.
* Practice therapeutic education on a regular basis

Exclusion Criteria

* Patients

* presenting contraindications to the use of Freestyle Libre® (known allergies to adhesive products, coagulation disorders, not treated with insulin therapy or with less than 3 insulin injections per day or continuously, not requiring glycemic monitoring or less than 3 times a day)
* Patient refusing to follow the education program,
* Minors, patients under administrative or judicial supervision)
* Pregnant women,
* Patients who cannot be contacted in an emergency,
* Persons in a position to give their consent but with an inability to read / write the French language.
* Patients who do not have an email address or a phone allowing internet use.
* Caregivers

* Failure to register with the professional order (except those of the Army Health Service who are exempt)
* Non-possession of the 40-hour therapeutic education training certificate.
* Not practicing FSL education
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Direction Centrale du Service de Santé des Armées

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hôpital Avicenne

Bobigny, , France

Site Status

Hopital d'Instruction des Armées Bégin

Saint-Mandé, , France

Site Status

Countries

Review the countries where the study has at least one active or historical site.

France

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020PPRC11

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.